Distinct Functional Differences of Human Progesterone Receptors A and B on Gene Expression and Growth Regulation in Two Endometrial Carcinoma Cell Lines-Reference-Cited by-同舟云学术

Distinct Functional Differences of Human Progesterone Receptors A and B on Gene Expression and Growth Regulation in Two Endometrial Carcinoma Cell Lines

Published:2003-01 Issue:1 Volume:10 Page:49-57
ISSN:1071-5576
Container-title:Journal of the Society for Gynecologic Investigation
language:en
Short-container-title:Journal of the Society for Gynecologic Investigation

Author:

Smid-Koopman Ellen¹,Blok Leen J.,Kühne, Liesbeth C. M.,Burger Curt W.,Helmerhorst Thoe J. M.,Brinkman Albert O.,Huikeshoven Frans J.²

Affiliation:

1. Department of Obstetrics and Gynecology, Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, The Netherlands

2. Departments of Obstetrics and Gynaecology, and Reproduction and Development, Erasmus Medical Center, Rotterdam, The Netherlands

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology

Link

http://journals.sagepub.com/doi/pdf/10.1177/107155760301000110

Reference40 articles.

1. Disruption of estrogen signaling does not prevent progesterone action in the estrogen receptor knockout mouse uterus

2. The Influence of 17β-Estradiol on Patterns of Cell Division in the Uterus

3. Influence of oestrogen and progesterone on macrophage distribution in the mouse uterus

4. THE INHIBITION BY PROGESTERONE OF UTERINE EPITHELIAL PROLIFERATION IN THE MOUSE

5. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Krüppel-like factor 12 decreases progestin sensitivity in endometrial cancer by inhibiting the progesterone receptor signaling pathway;Translational Oncology;2024-09

2. Identification of novel biomarkers and potential molecular targets for uterine cancer using network-based approach;Pathology - Research and Practice;2024-08

3. Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy;Gynecologic and Obstetric Pathology;2024

4. Endometrial Carcinogenesis;Gynecologic and Obstetric Pathology;2024

5. Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma;Cancers;2022-12-15